18 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... Diabetes #Diabetic #Medications ... #Pharmacology # ... Dosing #Dosing # ... Renal #Impairment #CKD
Adjusted Pain Medication Dosing based on GFR

#Renal #Dosing #Pain #Pharmacology #Opiates #CKD #Gabapentin #Table
Adjusted Pain Medication ... Dosing based on ... GFR #Renal #Dosing ... #Pain #Pharmacology ... #Opiates #CKD #
Reduced DOAC Dosing for Atrial Fibrillation 

#DOAC #Reduced #Dosing #Reduction #Dose #Anticoagulation #Pharmacology #AFib #Renal #CKD
Reduced DOAC Dosing ... DOAC #Reduced #Dosing ... Anticoagulation #Pharmacology ... #AFib #Renal #CKD ... AtrialFibrillation #Indications
Pain Assessment and Management Initiative (PAMI) - Transdermal Medications

#Management #Pain #Pharmacology #Transdermal #Topical #Medications #Doses #Dosing
- Transdermal Medications ... Management #Pain #Pharmacology ... #Transdermal #Topical ... #Medications #Doses ... #Dosing #Table
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
Agents to Treat Hyperkalemia ... and sodium • Dosing ... binds magnesium • Dosing ... and calcium • Dosing ... #medications #pharmacology
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pocket Cards - Pharmacologic ... adults, <3g in CKD ... avoid NSAIDs if CKD ... • Topical: Lidocaine ... Table #Ladder #medications
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
patients with CKD ... restricted due to hypercalcemia ... Purposes Only* #CKD ... Hyperphosphatemia #Dose #Dosing ... #Pharmacology #
Atopic Dermatitis - Topical Treatment Options 
First Line: Topical Corticosteroids 
  - High Potency: Betamethasone
therapy is non-pharmacologic ... If patients using ... If all topical products ... #Treatment #Medications ... #Pharmacology #
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
: Treatment of Hyperkalemia ... oral suspension DOSING ... patients with CKD ... ACE inhibitors, ... #Pharmacology
Long-Acting Injectable (LAI) - Atypical Antipsychotics 
INVEGA TRINZA 3 MONTHS 
ARISTADA 2 MONTHS 
INVEGA 1 MONTH
SUSTENNA
Injectable (LAI) - Atypical ... Adherence to daily medications ... which requires dosing ... only requires dosing ... Antipsychotics #Pharmacology